ALAGILLE SYNDROME ALLIANCE
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$640,163
Cash & Equivalents
66%
Investments
32%
Prepaid Expenses
2%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$6,036
Payables & Accruals
76%
Deferred Revenue
24%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$432,130
$420,959
-3%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
$15,876
-
Investments
$69,421
$203,328
+193%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$501,551
$640,163
+28%
Liabilities
2023
2024
Change
Payables & Accruals
$2,780
$4,588
+65%
Grants Payable
-
-
-
Deferred Revenue
-
$1,448
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$2,780
$6,036
+117%
Net assets
2023
2024
Change
Restricted Net Assets
$28,437
$28,437
+0%
Unrestricted Net Assets
$470,334
$605,690
+29%
Net assets
2023
2024
Change
Net assets
+$498,771
+$634,127
+27%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)